In a four-month comparison, marijuana smoke caused earlier and more severe airway hyperresponsiveness, inflammation, and emphysema in mice than tobacco smoke.
Read this if you smoke cannabis and want to understand the potential respiratory risks compared to tobacco.
Marijuana smoke caused airway hyperreactivity in 1 week vs. 2 months for tobacco
What the researchers found
This study provided the first systematic, head-to-head comparison of marijuana and tobacco smoke effects on mouse lungs over four months of daily exposure.
Marijuana inhalation triggered severe bronchial hyperreactivity within just one week. By one month, mice showed characteristic perivascular and peribronchial edema, atelectasis (collapsed lung tissue), apical emphysema, and neutrophil/macrophage infiltration. Damage progressively worsened, with destroyed bronchial mucosa, goblet cell hyperplasia, and severe emphysema by four months.
In comparison, tobacco smoke did not induce hyperresponsiveness until two months and caused inflammatory cell infiltration later with only mild emphysema.
Critically, the lung damage from marijuana smoke was not mediated by the CB1 cannabinoid receptor. Mice genetically lacking CB1 receptors showed the same airway hyperresponsiveness and inflammation, indicating the damage comes from the smoke itself, not from cannabinoid signaling.
Why it matters
This is the first controlled animal study systematically comparing marijuana and tobacco smoke lung effects. The finding that marijuana caused earlier and more severe damage challenges assumptions that marijuana smoke is less harmful than tobacco. The CB1-independence of the damage means this is a combustion problem, not a cannabinoid problem.
The numbers in context
Bronchial hyperreactivity appeared after 1 week with marijuana vs. 2 months with tobacco. Severe emphysema, atelectasis, and tissue destruction developed over 4 months of marijuana exposure. Tobacco caused only mild emphysema in the same timeframe.
How the study worked
CD1 mice underwent four months of daily whole-body marijuana smoke exposure, with systematic assessment at weekly and monthly intervals. Measurements included unrestrained whole-body plethysmography (bronchial responsiveness), flow cytometry (bronchoalveolar lavage cell profiles), spectrophotometry (myeloperoxidase activity), ELISA (inflammatory cytokines), and histopathology. CB1 receptor knockout mice were used to test receptor involvement.
What this study cannot tell us
Mouse lungs differ from human lungs in anatomy and immune response. The exposure protocol (daily whole-body exposure) may not reflect typical human smoking patterns. The study did not assess vaporized cannabis or distinguish between different smoking frequencies.
How to read the evidence
Controlled animal study with systematic methodology and CB1 knockout validation. Preliminary because animal findings may not directly translate to human smoking patterns.
When this study was published
Published in 2017.
The bigger picture
These findings support a combustion-specific risk for marijuana smoking that is separate from any pharmacological effect of cannabinoids. This distinction matters for harm reduction: alternative delivery methods (edibles, vaporizers) could potentially avoid these respiratory effects while still delivering cannabinoids.
Questions still open
- Do human marijuana smokers show the same accelerated lung damage compared to tobacco smokers? Would vaporized cannabis avoid these respiratory effects? Does the amount of marijuana typically smoked (usually less than tobacco) offset the per-session damage?
Common questions
Is marijuana smoke worse for your lungs than tobacco?
Is the lung damage from marijuana caused by THC?
Read the original research
Marijuana smoke induces severe pulmonary hyperresponsiveness, inflammation, and emphysema in a predictive mouse model not via CB1 receptor activation.
American journal of physiology. Lung cellular and molecular physiology, 313(2), L267-L277
Citation
Helyes, Z; Kemény, Á; Csekő, K; Szőke, É; Elekes, K; Mester, M; Sándor, K; Perkecz, A; Kereskai, L; Márk, L; Bona, Á; Benkő, A; Pintér, E; Szolcsányi, J; Ledent, C; Sperlágh, B; Molnár, T F. (2017). Marijuana smoke induces severe pulmonary hyperresponsiveness, inflammation, and emphysema in a predictive mouse model not via CB1 receptor activation.. American journal of physiology. Lung cellular and molecular physiology, 313(2), L267-L277. https://doi.org/10.1152/ajplung.00354.2016
Explore the wider topic
- Cannabis and Your Cardiovascular System: Heart Risk, Stroke, and What the Research Shows
- Cannabis and Your Heart: What the Cardiovascular Research Shows
- Coughing Up Black Stuff After Quitting Weed: What It Means
- Lung Recovery After Quitting Weed: The Complete Timeline
- Weed and Your Lungs: Recovery Timeline After Quitting
- Quitting Weed as a Woman: Hormones, Cycles, and Recovery
- Cannabis, Weight, and Diet: What Quitting Does to Your Appetite
- Sex After Quitting Weed: What Changes and What Doesn't
- Cannabis and Driving: DUI Laws, Impairment Science, and What You Need to Know
- Weed and Acne: Can Quitting Cannabis Clear Your Skin?
- Weed and Fertility: What Couples Should Know
- Weed and Your Gut: How Cannabis Affects Digestion
- Weed and Your Heart: Cardiovascular Effects and Recovery
- Weed, Testosterone, and Male Health: What the Research Actually Shows